Rep. Steve Rothman and Englewood Hospital and Medical Center officials in New Jersey recently announced $4.7 million in funding from the U.S. Department of Defense to train military medical professionals in bloodless medicine.
Since 1994, The Institute for Patient Blood Management & Bloodless Medicine and Surgery at Englewood Hospital and Medical Center has established itself as a world-recognized leader in patient blood management.
To date more than 50,000 patients from the U.S. and abroad have received medical treatment and undergone highly complex procedures such as brain, open-heart, orthopedic and gastrointestinal surgeries without blood transfusions at the hospital.
The hospital has trained more than 100 physicians in the procedures, says a press release, and now with the new government grant hundreds more military and civilian physicians from across the U.S. and internationally will learn the statistically proven life saving procedures.
Congressman Rothman announced at a press conference, "I am very happy to deliver this latest batch of federal funds from Washington, DC, $1.49 million, to Englewood Hospital and Medical Center (EHMC). This now brings the total for the Hospital's bloodless medicine program to $4.69 million and for all EHMC programs I was able to secure over six million in federal dollars that I have brought home since 2002. These resources were appropriated for the hospital's breast care center, emergency room, radiology information system, and the Institute for the Advancement of Bloodless Medicine. Englewood Hospital does such important work and I look forward to continuing to help," reported PR Newswire.
Rothman told NorthJersey.com, “I’m very proud we were able to get this included in the defense budget. It not only saves lives and helps alleviate suffering for our military personnel and veterans, it will also save federal tax dollars.’’
Dr. Aryeh Shander, executive medical director of the institute told NorthJersey.com, "Bloodless medicine appeals to many doctors because it carries low risk of post-operative infection when compared with procedures requiring transfusions. It can also be useful during times of war or natural disasters when blood supplies are low or unavailable."
Douglas A. Duchak, President and CEO of the Medical Center said proudly, "Receiving this funding is an honor for Englewood Hospital and a confirmation of our status as a world leader in the practice of bloodless medicine and surgery. For a community hospital to receive this recognition is a remarkable achievement."